Genyang Cheng

779 total citations
40 papers, 578 citations indexed

About

Genyang Cheng is a scholar working on Nephrology, Molecular Biology and Cancer Research. According to data from OpenAlex, Genyang Cheng has authored 40 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Nephrology, 10 papers in Molecular Biology and 8 papers in Cancer Research. Recurrent topics in Genyang Cheng's work include Renal Diseases and Glomerulopathies (13 papers), Dialysis and Renal Disease Management (5 papers) and Acute Kidney Injury Research (5 papers). Genyang Cheng is often cited by papers focused on Renal Diseases and Glomerulopathies (13 papers), Dialysis and Renal Disease Management (5 papers) and Acute Kidney Injury Research (5 papers). Genyang Cheng collaborates with scholars based in China, United Kingdom and Canada. Genyang Cheng's co-authors include Zhanzheng Zhao, Jing Xiao, Zhangsuo Liu, Dong Liu, Jin Shang, Dong Liu, Dahai Yu, Jing Xiao, Shan Lu and Ying Chen and has published in prestigious journals such as Scientific Reports, Journal of Controlled Release and Journal of the American Society of Nephrology.

In The Last Decade

Genyang Cheng

35 papers receiving 562 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Genyang Cheng China 15 206 192 133 73 67 40 578
Keita Mori Japan 13 223 1.1× 141 0.7× 58 0.4× 134 1.8× 50 0.7× 32 594
Carolina Lavoz Spain 15 352 1.7× 171 0.9× 69 0.5× 63 0.9× 181 2.7× 26 738
Yong‐Ke You China 11 400 1.9× 219 1.1× 189 1.4× 61 0.8× 82 1.2× 17 686
Yan Dai China 15 431 2.1× 295 1.5× 128 1.0× 51 0.7× 126 1.9× 27 884
Yunfeng Xia China 15 225 1.1× 174 0.9× 40 0.3× 64 0.9× 132 2.0× 37 643
Qisheng Yao China 10 366 1.8× 108 0.6× 176 1.3× 60 0.8× 52 0.8× 13 541
Wanxin Tang China 13 239 1.2× 104 0.5× 76 0.6× 63 0.9× 70 1.0× 30 494
Mária Godó Hungary 10 237 1.2× 133 0.7× 130 1.0× 24 0.3× 76 1.1× 18 478
Angela Koudijs Netherlands 10 250 1.2× 130 0.7× 71 0.5× 57 0.8× 76 1.1× 18 607
Kiichiro Jinde Japan 12 167 0.8× 354 1.8× 54 0.4× 66 0.9× 86 1.3× 19 624

Countries citing papers authored by Genyang Cheng

Since Specialization
Citations

This map shows the geographic impact of Genyang Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Genyang Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Genyang Cheng more than expected).

Fields of papers citing papers by Genyang Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Genyang Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Genyang Cheng. The network helps show where Genyang Cheng may publish in the future.

Co-authorship network of co-authors of Genyang Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Genyang Cheng. A scholar is included among the top collaborators of Genyang Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Genyang Cheng. Genyang Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Qianqian, Bo Zhang, Yaling Zhai, et al.. (2025). The role of innate lymphoid cells in kidney disease. Cytokine & Growth Factor Reviews. 85. 146–157.
2.
Cheng, Genyang, Xiaoxue Zhang, Zheng Wang, et al.. (2025). Single nucleus RNA-seq reveals the process from onset to chronic kidney disease in IgA nephropathy. Scientific Reports. 15(1). 22780–22780. 1 indexed citations
3.
Yang, Rong, Li Xu, Qing Tian, et al.. (2025). Melanoma MHC-I-membrane-encapsulated Cu@ferrihydrite induces ferroptosis/cuproptosis and systematic immunity against tumor. Journal of Controlled Release. 388(Pt 1). 114281–114281. 2 indexed citations
4.
Wen, Lu, Qianqian Li, Genyang Cheng, Yuan Zhang, & Zhanzheng Zhao. (2024). Prognostic value of serum complement cleavage factor Bb in idiopathic membranous nephropathy and establishment of nomogram model. Scientific Reports. 14(1). 27266–27266.
5.
Li, Lei, Jianxiang Zhang, Ranran Sun, et al.. (2024). Immune Dysregulation in SARS-CoV-2 patients coinfected with Mycobacterium tuberculosis (Mtb) or HIV in China. BMC Public Health. 24(1). 556–556. 1 indexed citations
6.
7.
Yang, Rong, Qing Tian, Zixi Wang, et al.. (2024). Immunoactivation by Cutaneous Blue Light Irradiation Inhibits Remote Tumor Growth and Metastasis. ACS Pharmacology & Translational Science. 7(4). 1055–1068. 5 indexed citations
8.
Zhao, Mengmeng, et al.. (2023). Dual-targeted nanoparticles with removing ROS inside and outside mitochondria for acute kidney injury treatment. Nanomedicine Nanotechnology Biology and Medicine. 55. 102725–102725. 11 indexed citations
9.
Zhang, Lijie, Zhengguang Chen, Liwei Guo, et al.. (2021). Preliminary study on the application of renal ultrasonography radiomics in the classification of glomerulopathy. BMC Medical Imaging. 21(1). 115–115. 12 indexed citations
10.
Li, Fanghua, Genyang Cheng, Dong Liu, et al.. (2020). Compound C Protects Against Cisplatin-Induced Nephrotoxicity Through Pleiotropic Effects. Frontiers in Physiology. 11. 614244–614244. 10 indexed citations
11.
Lu, Shan, Dong Liu, Jing Xiao, Genyang Cheng, & Zhanzheng Zhao. (2020). Abnormal lncRNA CCAT1/microRNA-155/SIRT1 axis promoted inflammatory response and apoptosis of tubular epithelial cells in LPS caused acute kidney injury. Mitochondrion. 53. 76–90. 29 indexed citations
12.
Zhai, Yaling, Yuanyuan Qi, Yanna Dou, et al.. (2019). Elevated hsa‐miR‐590‐3p expression down‐regulates HMGB2 expression and contributes to the severity of IgA nephropathy. Journal of Cellular and Molecular Medicine. 23(11). 7299–7309. 9 indexed citations
13.
Jiang, Rong, Xiaoyang Wang, Lijie Zhang, et al.. (2019). Association between metabolic syndrome and prognosis in patients with peritoneal dialysis. 35(3). 184–190. 1 indexed citations
14.
Dou, Yanna, Peipei Wang, Bei Zhang, et al.. (2019). Value of the baseline Geriatric Nutritional Risk Index in evaluating the prognosis of maintenance peritoneal dialysis patients. 35(11). 841–847. 1 indexed citations
15.
Shang, Jin, et al.. (2019). Identification of key lncRNAs contributing to diabetic nephropathy by gene co-expression network analysis. Scientific Reports. 9(1). 3328–3328. 18 indexed citations
16.
Dou, Yanna, Dong Liu, Li Zhang, et al.. (2017). Accuracy of glomerular filtration rate equations for chronic kidney disease patients at the G3a stage: a single-center cross-sectional study. BMC Research Notes. 10(1). 107–107. 3 indexed citations
17.
Dou, Yanna, Dong Liu, Chunyan Wang, et al.. (2016). The accuracy of the anti-phospholipase A2 receptor antibody in the diagnosis of idiopathic membranous nephropathy: a comparison of different cutoff values as measured by the ELISA method. International Urology and Nephrology. 48(6). 845–849. 25 indexed citations
18.
Zhang, Na, Genyang Cheng, Xianzhi Liu, & Fengjiang Zhang. (2014). Expression of Bcl-2 and NF-κB in brain tissue after acute renal ischemia-reperfusion in rats. Asian Pacific Journal of Tropical Medicine. 7(5). 386–389. 16 indexed citations
19.
Tang, Lin, Hui Li, Rong Gou, et al.. (2014). Endothelin-1 mediated high glucose-induced epithelial–mesenchymal transition in renal tubular cells. Diabetes Research and Clinical Practice. 104(1). 176–182. 18 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Keita Mori Breakdown of academic impact, for papers by Carolina Lavoz Breakdown of academic impact, for papers by Yong‐Ke You Breakdown of academic impact, for papers by Yan Dai Breakdown of academic impact, for papers by Yunfeng Xia Breakdown of academic impact, for papers by Qisheng Yao Breakdown of academic impact, for papers by Wanxin Tang Breakdown of academic impact, for papers by Mária Godó Breakdown of academic impact, for papers by Angela Koudijs Breakdown of academic impact, for papers by Kiichiro Jinde
Rankless by CCL
2026